S100B Mediates Stemness of Ovarian Cancer Stem-Like Cells Through Inhibiting p53
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
S100B Mediates Stemness of Ovarian Cancer Stem-Like Cells Through Inhibiting p53
Authors
Keywords
-
Journal
STEM CELLS
Volume 35, Issue 2, Pages 325-336
Publisher
Wiley
Online
2016-08-09
DOI
10.1002/stem.2472
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Silencing of CD24 Enhances the PRIMA-1-Induced Restoration of Mutant p53 in Prostate Cancer Cells
- (2015) W. Zhang et al. CLINICAL CANCER RESEARCH
- HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levels
- (2015) Francesca Puca et al. Oncotarget
- RAGE overexpression confers a metastatic phenotype to the WM115 human primary melanoma cell line
- (2014) Varsha Meghnani et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Platinum sensitivity and CD133 expression as risk and prognostic predictors of central nervous system metastases in patients with epithelial ovarian cancer
- (2014) Bo-lin Liu et al. BMC CANCER
- Complex Formation between S100B Protein and the p90 Ribosomal S6 Kinase (RSK) in Malignant Melanoma Is Calcium-dependent and Inhibits Extracellular Signal-regulated Kinase (ERK)-mediated Phosphorylation of RSK
- (2014) Kira G. Hartman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells
- (2014) Margaret Gil et al. JOURNAL OF IMMUNOLOGY
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- miR-34 Cooperates with p53 in Suppression of Prostate Cancer by Joint Regulation of Stem Cell Compartment
- (2014) Chieh-Yang Cheng et al. Cell Reports
- Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling
- (2013) Guobin He et al. CELL
- S100B Promotes Glioma Growth through Chemoattraction of Myeloid-Derived Macrophages
- (2013) H. Wang et al. CLINICAL CANCER RESEARCH
- Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer
- (2013) T Xiang et al. ONCOGENE
- Evaluating cell lines as tumour models by comparison of genomic profiles
- (2013) Silvia Domcke et al. Nature Communications
- Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer
- (2012) Yang Jiang et al. Gastric Cancer
- Autocrine CCL5 Signaling Promotes Invasion and Migration of CD133+Ovarian Cancer Stem-Like Cells via NF-κB-Mediated MMP-9 Upregulation
- (2012) Haixia Long et al. STEM CELLS
- Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
- (2011) I. A. Silva et al. CANCER RESEARCH
- S100B promotes the proliferation, migration and invasion of specific brain metastatic lung adenocarcinoma cell line
- (2011) Weifeng Jiang et al. CELL BIOCHEMISTRY AND FUNCTION
- S100B protein in neurodegenerative disorders
- (2011) Johann Steiner et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Overexpression of S100B, TM4SF4, and OLFM4 Genes Is Correlated with Liver Metastasis in Taiwanese Colorectal Cancer Patients
- (2011) Ming-Yii Huang et al. DNA AND CELL BIOLOGY
- S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling
- (2011) Alejandro Villarreal et al. JOURNAL OF NEUROCHEMISTRY
- Differentiation Therapy: Targeting Human Renal Cancer Stem Cells with Interleukin 15
- (2011) Sandy Azzi et al. JNCI-Journal of the National Cancer Institute
- Erratum: p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs
- (2011) Chun-Ju Chang et al. NATURE CELL BIOLOGY
- p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs
- (2011) Chun-Ju Chang et al. NATURE CELL BIOLOGY
- Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer
- (2011) L Cao et al. ONCOGENE
- S100B Protein Expressions as an Independent Predictor of Early Relapse in UICC Stages II and III Colon Cancer Patients after Curative Resection
- (2010) Chi-Ching Hwang et al. ANNALS OF SURGICAL ONCOLOGY
- Coexpression of Oct4 and Nanog Enhances Malignancy in Lung Adenocarcinoma by Inducing Cancer Stem Cell-Like Properties and Epithelial-Mesenchymal Transdifferentiation
- (2010) S.-H. Chiou et al. CANCER RESEARCH
- The Calcium-binding Protein S100B Down-regulates p53 and Apoptosis in Malignant Melanoma
- (2010) Jing Lin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
- (2010) Christophe Ginestier et al. JOURNAL OF CLINICAL INVESTIGATION
- Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
- (2009) Nawneet K. Kurrey et al. STEM CELLS
- The prognostic value of serum S100B in patients with cutaneous melanoma: A meta-analysis
- (2008) Simone Mocellin et al. INTERNATIONAL JOURNAL OF CANCER
- An integrative model for recurrence in ovarian cancer
- (2008) Alexandros Laios et al. Molecular Cancer
- p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation
- (2008) Hongwu Zheng et al. NATURE
- Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
- (2008) T Baba et al. ONCOGENE
- Progenitor/stem cells give rise to liver cancer due to aberrant TGF- and IL-6 signaling
- (2008) Y. Tang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started